Advertisement

Tissue Bioengineering and Artificial Organs

  • Sara Llames
  • Eva García
  • Jesús Otero Hernández
  • Álvaro MeanaEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 741)

Abstract

The scarcity of organs and tissues for transplant and the need of immunosuppressive drugs to avoid rejection constitute two reasons that justify organ and tissue production in the laboratory. Tissue engineering based tissues (TE) could allow to regenerate the whole organ from a fragment or even to produce several organs from an organ donor for grafting purposes. TE is based in: (1) the ex vivo expansion of cells, (2) the seeding of these expanded cells in tridimensional structures that mimic physiological conditions and, (3) grafting the prototype. In order to graft big structures it is necessary that the organ or tissue produced “ex vivo” bears a vascular tree to ensure the nutrition of its deep layers. At present, no technology has been developed to provide this vascular tree to TE derived products. Thus, these tissues must be thin enough to acquire nutrients during the first days by diffusion from surrounding tissues. This fact constitutes nowadays the greatest limitation of technologies for organ development in the laboratory.

In this chapter, all these problems and their possible solutions are commented. Also, the present status of TE techniques in the regeneration of different organ systems is reviewed.

Keywords

Tissue Engineering Stem Cell Transplantation Acute Liver Failure Tissue Engineer Vascular Tree 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moreno-Borchart A. Building organs piece by piece. EMBO rep 2004; 5:1025–1028.PubMedCrossRefGoogle Scholar
  2. 2.
    Falke G, Atala A. Reconstrucción de tejidos y órganos utilizando ingeniería tisular. Arch Argent Pediatr 2000; 98:103–115.Google Scholar
  3. 3.
    O’ Connor NE, Mulliken JB, Banks-Schlegal S et al. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981; 1:75–78.CrossRefGoogle Scholar
  4. 4.
    Vacanti C. The history of tissue engineering. J Cell Mol Med 2006; 10:569–576.PubMedCrossRefGoogle Scholar
  5. 5.
    Brittberg M, Lindahl A, Nilsson A et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331:889–895.PubMedCrossRefGoogle Scholar
  6. 6.
    Perin L, Giuliani S, Sedrakyan S et al. Stem cell and regenerative science applications in the development of bioengineering of renal tissue. Pediatr Res 2008; 63:467–471.PubMedCrossRefGoogle Scholar
  7. 7.
    Choumerianou D, Dimitriou H, Kalmanti M. Stem cells: promises versus limitations. Tissue Eng Part B Rev 2008; 14:53–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Da Silva Meirelles L, Caplan A, Beyer N. In search of the in vivo identity of mesenchymal. Stem Cells 2008; 26:2287–2299.PubMedCrossRefGoogle Scholar
  9. 9.
    Toda A, Okabe M, Yoshida T et al. The potential of amniotic membrane/amnion-derived cells for the regeneration of various tissues. J Pharmacol Sci 2007; 105:215–228.PubMedCrossRefGoogle Scholar
  10. 10.
    De Coppi P, Bartsch G Jr, Siddiqui MM et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25:100–106.PubMedCrossRefGoogle Scholar
  11. 11.
    Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:1–12.CrossRefGoogle Scholar
  12. 12.
    Raya A, Rodriguez-Piza I, Navarro S et al. A protocol describing the genetic correction of somatic human cells and subsequent genration of iPSC cells. Nat Protoc 2010; 5:647–660.PubMedCrossRefGoogle Scholar
  13. 13.
    Patterson TE, Kumagai K, Griffith L et al. Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am 2008; 90 Suppl 1:111–119.PubMedCrossRefGoogle Scholar
  14. 14.
    Lee J, Cuddihy M, Kotov N. Three-dimensional cell culture matrices: State of the art. Tissue Eng Part B Rev 2008; 14:61–86.PubMedCrossRefGoogle Scholar
  15. 15.
    Mironov V, Boland T, Trusk T et al. Organ printing: computer-aided jet-based 3D tissue engineering. Trends in Biotechnology 2003; 21:157–161.PubMedCrossRefGoogle Scholar
  16. 16.
    Ott HC, Matthiesen TS, Goh SK et al. Perfussion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med 2008; 14:213–221.PubMedCrossRefGoogle Scholar
  17. 17.
    Grayson WL, Chao PH, Marolt D et al. Engineering custom-designed osteochondral tissue grafts. Trends Biotechnol 2008; 26:181–189.PubMedCrossRefGoogle Scholar
  18. 18.
    Bilodeau K, Mantovani D. Bioreactors for tissue engineering: Focus on mechanical constraints. A comparative review. Tissue Engineering 2006; 12:2367–2383.PubMedCrossRefGoogle Scholar
  19. 19.
    Freed L, Guilak F, Guo E et al. Advanced tools for tissue engineering: scaffolds, biorreactors and signaling. Tissue Engineering 2006; 12:3285–3305.PubMedCrossRefGoogle Scholar
  20. 20.
    Taylor DA. From stem cells and cadaveric matrix to engineered organs. Current Opinion in Biotechnology 2009; 20:598–605.PubMedCrossRefGoogle Scholar
  21. 21.
    Segers V, Lee RT. Stem cell therapy for cardiac disease. Nature 2008; 451:937–942.PubMedCrossRefGoogle Scholar
  22. 22.
    Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress and challenges. Ann Biomed Eng 2006; 34:1799–1819.PubMedCrossRefGoogle Scholar
  23. 23.
    Vesely I. Heart valve tissue engineering. Circ Res 2005; 97:743–755.PubMedCrossRefGoogle Scholar
  24. 24.
    L’Heureux N, Dusserre N, Marina A et al. Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat Clin Pract Cardiovasc Med 2007; 4:389–395.PubMedCrossRefGoogle Scholar
  25. 25.
    Meinhart JG, Deutsch M, Fischlein T et al. Clinical autologous in vitro endothelialization of 153 infrainguinalePTFE grafts. Ann Thorac Surg 2001; 71:S327–S331.PubMedCrossRefGoogle Scholar
  26. 26.
    Shin’oka T, Matsumura G, Hibino N et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005; 129:1330–1338.CrossRefGoogle Scholar
  27. 27.
    L’Heureux N, Dussrre N, Koning G et al. Human tissue engineered blood vessel for adult arterial revascularization. Nat Med 2006; 12:361–365.PubMedCrossRefGoogle Scholar
  28. 28.
    Guillemette M, Gauvin R, Perron C et al. Tissue-Engineered vascular adventitia with vasa vasorum improves graft integration and vascularization through inosculation. Tissue Eng Part A 2010; 16:2617–2626.PubMedCrossRefGoogle Scholar
  29. 29.
    Petersen T, Calle E, Zhao L et al. Tissue-engineered lungs for in vivo implantation. B. Science 2010; 329:538–541.Google Scholar
  30. 30.
    Macchiarini P, Jungebluth P, Go T et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008; 372:2023–2030.PubMedCrossRefGoogle Scholar
  31. 31.
    Fieguel H, Kaufmann P, Bruns H et al. Hepatic tissue engineering: from transplantation to customized cell-based directed therapies from the laboratory. J Cell Mol Med 2008; 12:56–66.CrossRefGoogle Scholar
  32. 32.
    Stadlbauer V, Jalan R. Acute liver failure: liver support therapies. Curr Opin Crit Care 2007; 13:215–221.PubMedCrossRefGoogle Scholar
  33. 33.
    Naruse K, Tang W, Makuuchi M. Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients. World J Gastroenterol 2007; 13:1516–1521.PubMedGoogle Scholar
  34. 34.
    Uygun BE, Soto-Gutierrez A, Izamis ML et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nature Medicine 2010; 16:814–820.PubMedCrossRefGoogle Scholar
  35. 35.
    Atala A. Bioengineered tissues for urogenital repair in children. Pediatr Res 2008; 63:569–575.PubMedCrossRefGoogle Scholar
  36. 36.
    Fissell WH, Manley S, Westover A et al. Differentiated growth of human renal tubule cells on thin-film and nanostructured materials. ASAIO J 2006; 52:221–227.PubMedCrossRefGoogle Scholar
  37. 37.
    Romagnoli G, De Luca M, Faranda F et al. Treatment of posterior hypospadias by the autologous graft of cultured urethral epithelium. N Engl J Med 1990; 323:527–530.PubMedCrossRefGoogle Scholar
  38. 38.
    Atala A, Bauer SB, Soker S et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367:1241–1246.PubMedCrossRefGoogle Scholar
  39. 39.
    Kneser U, Schaefer DJ, Polykandriotis E et al. Tissue engineering of bone: the reconstructive surgeon’s point of view. J Cell Mol Med 2006; 10:7–19.PubMedCrossRefGoogle Scholar
  40. 40.
    Clar C, Cummins E, McIntyre L et al. Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. Health Technol Assess 2005; 9 nº 47.Google Scholar
  41. 41.
    Petrigliano F, McAllister D, Wu B. Tissue engineering for anterior cruciate ligament reconstruction: a review of current strategies. Arthroscopy 2006; 22:441–451.PubMedCrossRefGoogle Scholar
  42. 42.
    Atiyeh BS, Costagliola M. Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns 2007; 33:405–413.PubMedCrossRefGoogle Scholar
  43. 43.
    Llames S, Del Rio M, Larcher F et al. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Transplantation 2004; 7:350–355.CrossRefGoogle Scholar
  44. 44.
    Rama P, Matiska S, Paganoni G et al. Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med 2010; 363:147–155.PubMedCrossRefGoogle Scholar
  45. 45.
    Chalfoun CT, Wirth GA, Evans GR. Tissue engineered nerve construct: Where do we stand? J Cell Mol Med 2006; 10:309–317.PubMedCrossRefGoogle Scholar
  46. 46.
    Willerth S, Sakiyama-Elbert S. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev 2007; 59:325–338.PubMedCrossRefGoogle Scholar
  47. 47.
    Cramer SC. Repairing human brain after stroke. II Restorative Therapies. Ann Neurol 2008; E63:549–560.CrossRefGoogle Scholar
  48. 48.
    Thuret S, Moon L, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 2006; 7:628–643.PubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2012

Authors and Affiliations

  • Sara Llames
    • 1
  • Eva García
    • 1
  • Jesús Otero Hernández
    • 2
  • Álvaro Meana
    • 1
    Email author
  1. 1.Tissue Engineering Unit, Community Centre for Blood and Tissues of AsturiasBiomedical Network Research Centre on Rare DiseasesOviedoSpain
  2. 2.Transplant Coordination UnitHospital Universitario Central de AsturiasOviedoSpain

Personalised recommendations